3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
6
Fallopian Tube Neoplasms
4
Carcinoma, Ovarian Epithelial
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Platinum-resistant Ovarian Cancer
1
Ovarian Cancer Recurrent
1
Melanoma
1
Lymphoma, Follicular
1
Lymphoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Adenoviridae Infections
1
Interventions
Cyclophosphamide
31
fludarabine
28
Whole-Body Irradiation
18
Mycophenolic Acid
18
venetoclax
14
Tacrolimus
14
fludarabine phosphate
13
Standard of Care
13
Specimen Handling
10
Practice Guidelines as Topic
10
Melphalan
10
Busulfan
10
Sirolimus
9
Thiotepa
8
Interviews as Topic
8
Azacitidine
8
Educational Status
7
trametinib
6
Surveys and Questionnaires
6
Methods
6
Mesna
6
Biopsy
6
thymoglobulin
5
Rituximab
5
Magnetic Resonance Spectroscopy
5
Filgrastim
5
Early Intervention, Educational
5
Behavior Therapy
5
Antilymphocyte Serum
5
Peripheral Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
1-dodecylpyridoxal
×
1 year
×
Clear all
No trials found.